EULAR points to consider for the use of imaging to guide interventional procedures in patients with rheumatic and musculoskeletal diseases (RMDs)Christian Dejaco, Pedro M Machado, Francesco Carubbi, Philipp Bosch, Lene Terslev, Giorgio Tamborrini, Luca Maria Sconfienza, Carlo Alberto Scirè, Sebastian Ruetten, Jef van Rompay, Fabian Proft, Costantino Pitzalis, Marina Obradov, Rikke Helene Moe, Vasco V MascarenhasSee the full list of authors
10 December 2021
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndromeGeorge C Drosos, Daisy Vedder, Eline Houben, Laura Boekel, Fabiola Atzeni, Sara Badreh, Dimitrios T Boumpas, Nina Brodin, Ian N Bruce, Miguel Ángel González-Gay, Søren Jacobsen, György Kerekes, Francesca Marchiori, Chetan Mukhtyar, Manuel Ramos-CasalsSee the full list of authors
2 February 2022
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGSKader Cetin Gedik, Lovro Lamot, Micol Romano, Erkan Demirkaya, David Piskin, Sofia Torreggiani, Laura A Adang, Thais Armangue, Kathe Barchus, Devon R Cordova, Yanick J Crow, Russell C Dale, Karen L Durrant, Despina Eleftheriou, Elisa M FazziSee the full list of authors
22 February 2022
Response to: ‘External validation of EULAR/ACR classification criteria for idiopathic inflammatory myopathies’ by Luu et alMasatoshi Jinnin, Akiko Ohta, Hitoshi Kohsaka
12 May 2020
External validation of EULAR/ACR classification criteria for idiopathic inflammatory myopathiesQueenie Luu, Jessica Day, Alix Hall, Vidya Limaye, Gabor Major
12 May 2020
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19Alessia Alunno, Aurélie Najm, Pedro M Machado, Heidi Bertheussen, Gerd-Rüdiger R Burmester, Francesco Carubbi, Gabriele De Marco, Roberto Giacomelli, Olivier Hermine, John D Isaacs, Isabelle Koné-Paut, César Magro-Checa, Iain B McInnes, Pier Luigi Meroni, Luca QuartuccioSee the full list of authors
7 October 2021
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritisGyörgy Nagy, Nadia M T Roodenrijs, Paco M J Welsing, Melinda Kedves, Attila Hamar, Marlies C van der Goes, Alison Kent, Margot Bakkers, Polina Pchelnikova, Etienne Blaas, Ladislav Senolt, Zoltan Szekanecz, Ernest H Choy, Maxime Dougados, Johannes WG JacobsSee the full list of authors
18 August 2021
EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritisKulveer Mankia, Heidi J Siddle, Andreas Kerschbaumer, Deshire Alpizar Rodriguez, Anca Irinel Catrina, Juan D Cañete, Andrew P Cope, Claire Immediato Daien, Kevin D Deane, Hani El Gabalawy, Axel Finckh, V Michael Holers, Marios Koloumas, Francesca Ometto, Karim RazaSee the full list of authors
6 August 2021
EULAR recommendations for intra-articular therapiesJacqueline Uson, Sebastián Cruz Rodriguez-García, Raul Castellanos-Moreira, Terence W O'Neill, Michael Doherty, Mikael Boesen, Hemant Pandit, Ingrid Möller Parera, Valentina Vardanyan, Lene Terslev, Willm Uwe Kampen, Maria-Antonietta D'Agostino, Francis Berenbaum, Elena Nikiphorou, Irene A PitsillidouSee the full list of authors
25 May 2021
2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritisElena Nikiphorou, Eduardo José Ferreira Santos, Andrea Marques, Peter Böhm, Johannes WJ Bijlsma, Claire Immediato Daien, Bente Appel Esbensen, Ricardo J O Ferreira, George E Fragoulis, Pat Holmes, Hayley McBain, George S Metsios, Rikke Helene Moe, Tanja A Stamm, Annette de ThurahSee the full list of authors
7 May 2021